Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators
AssigneePraecis Pharmaceuticals, Inc.
InventorMarc B. Garnick
Life of this patent
Estimating the term…
Abstract
Methods for treating hormone associated conditions, such as endometriosis, uterine leiomata, ovarian cancer, breast cancer, or vaginal bleeding, using LHRH antagonists and selective estrogen receptor modulators are disclosed. The methods include administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator. Pharmaceutical compositions and kits for use in the methods of the invention are also provided.
Claims46
A method for treating a hormone associated condition in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating a hormone associated condition in the subject.
A method for treating endometriosis in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating endometriosis in the subject.
A method for treating ovarian cancer in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating ovarian cancer in the subject.
A method for treating breast cancer in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating breast cancer in the subject.
A method for treating polycystic ovary syndrome in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating polycystic ovary syndrome in the subject.
A method for treating uterine leiomata in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating uterine leiomata in the subject.
A method for treating dysfunctional uterine bleeding in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating dysfunctional uterine bleeding in the subject.
A method for treating premenstrual syndrome in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating premenstrual syndrome in the subject.
A method for treating vaginal bleeding in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating vaginal bleeding in the subject.
A method for treating uterine fibroids in a subject, comprising administering to a subject a combination of an LHRH antagonist and a selective estrogen receptor modulator, thereby treating uterine fibroids in the subject.
Dependencies are inferred from the claim text.